Inventor
GOLDSTEIN JOEL
IL19 patents
⚠️ This page may combine multiple inventors who share the name “GOLDSTEIN JOEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELLDEX THERAPEUTICS INC
7 patentsUS10633444B2Apr 28, 2020
Agonistic antibodies that bind CD40
CELLDEX THERAPEUTICS INC12 citations91
US10941201B2Mar 9, 2021
Methods of inducing or enhancing an immune response comprising administering agonistic anti-CD40 antibodies
CELLDEX THERAPEUTICS INC2 citations70
US10865244B2Dec 15, 2020
Nucleic acids encoding agonistic antibodies that bind CD40
CELLDEX THERAPEUTICS INC1 citations70
US11459393B2Oct 4, 2022
Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs
CELLDEX THERAPEUTICS INC0 citations62
US11332537B2May 17, 2022
Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs
CELLDEX THERAPEUTICS INC1 citations62
US12297266B2May 13, 2025
Agonistic antibodies that bind human CD40 and uses thereof
CELLDEX THERAPEUTICS INC0 citations60
US7316812B2Jan 8, 2008
Cells expressing anti-Fc receptor binding components
CELLDEX THERAPEUTICS INC0 citations52
MEDAREX INC
5 patentsUS6682928B2Jan 27, 2004
Cells expressing anti-Fc receptor binding components
MEDAREX INC89 citations98
US6410690B1Jun 25, 2002
Therapeutic compounds comprised of anti-Fc receptor antibodies
MEDAREX INC91 citations98
US6365161B1Apr 2, 2002
Therapeutic compounds comprised of anti-FC receptor binding agents
MEDAREX INC113 citations98
US6270765B1Aug 7, 2001
Therapeutic compounds comprised of anti-Fc receptor antibodies
MEDAREX INC215 citations98
US5837243ANov 17, 1998
Therapeutic compounds comprised of anti-Fc receptor antibodies
MEDAREX INC545 citations98